Cargando…

Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study

Over the past decades, many studies used global outcome measures like the IQ when reporting cognitive outcome of pediatric brain tumor patients, assuming that intelligence is a singular and homogeneous construct. In contrast, especially in clinical neuropsychology, the assessment and interpretation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wegenschimmel, Barbara, Leiss, Ulrike, Veigl, Michaela, Rosenmayr, Verena, Formann, Anton, Slavc, Irene, Pletschko, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663794/
https://www.ncbi.nlm.nih.gov/pubmed/28779461
http://dx.doi.org/10.1007/s11060-017-2582-x
_version_ 1783274882525560832
author Wegenschimmel, Barbara
Leiss, Ulrike
Veigl, Michaela
Rosenmayr, Verena
Formann, Anton
Slavc, Irene
Pletschko, Thomas
author_facet Wegenschimmel, Barbara
Leiss, Ulrike
Veigl, Michaela
Rosenmayr, Verena
Formann, Anton
Slavc, Irene
Pletschko, Thomas
author_sort Wegenschimmel, Barbara
collection PubMed
description Over the past decades, many studies used global outcome measures like the IQ when reporting cognitive outcome of pediatric brain tumor patients, assuming that intelligence is a singular and homogeneous construct. In contrast, especially in clinical neuropsychology, the assessment and interpretation of distinct neurocognitive domains emerged as standard. By definition, the full scale IQ (FIQ) is a score attempting to measure intelligence. It is established by calculating the average performance of a number of subtests. Therefore, FIQ depends on the subtests that are used and the influence neurocognitive functions have on these performances. Consequently, the present study investigated the impact of neuropsychological domains on the singular “g-factor” concept and analysed the consequences for interpretation of clinical outcome. The sample consisted of 37 pediatric patients with medulloblastoma, assessed 0–3 years after diagnosis with the Wechsler Intelligence Scales. Information processing speed and visuomotor function were measured by the Trailmaking Test, Form A. Our findings indicate that FIQ was considerably impacted by processing speed and visuomotor coordination, which leaded to an underestimation of the general cognitive performance of many patients. One year after diagnosis, when patients showed the largest norm-deviation, this effect seemed to be at its peak. As already recommended in international guidelines, a comprehensive neuropsychological test battery is necessary to fully understand cognitive outcome. If IQ-tests are used, a detailed subtest analysis with respect to the impact of processing speed seems essential. Otherwise patients may be at risk for wrong decision making, especially in educational guidance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-017-2582-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5663794
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-56637942017-11-16 Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study Wegenschimmel, Barbara Leiss, Ulrike Veigl, Michaela Rosenmayr, Verena Formann, Anton Slavc, Irene Pletschko, Thomas J Neurooncol Clinical Study Over the past decades, many studies used global outcome measures like the IQ when reporting cognitive outcome of pediatric brain tumor patients, assuming that intelligence is a singular and homogeneous construct. In contrast, especially in clinical neuropsychology, the assessment and interpretation of distinct neurocognitive domains emerged as standard. By definition, the full scale IQ (FIQ) is a score attempting to measure intelligence. It is established by calculating the average performance of a number of subtests. Therefore, FIQ depends on the subtests that are used and the influence neurocognitive functions have on these performances. Consequently, the present study investigated the impact of neuropsychological domains on the singular “g-factor” concept and analysed the consequences for interpretation of clinical outcome. The sample consisted of 37 pediatric patients with medulloblastoma, assessed 0–3 years after diagnosis with the Wechsler Intelligence Scales. Information processing speed and visuomotor function were measured by the Trailmaking Test, Form A. Our findings indicate that FIQ was considerably impacted by processing speed and visuomotor coordination, which leaded to an underestimation of the general cognitive performance of many patients. One year after diagnosis, when patients showed the largest norm-deviation, this effect seemed to be at its peak. As already recommended in international guidelines, a comprehensive neuropsychological test battery is necessary to fully understand cognitive outcome. If IQ-tests are used, a detailed subtest analysis with respect to the impact of processing speed seems essential. Otherwise patients may be at risk for wrong decision making, especially in educational guidance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-017-2582-x) contains supplementary material, which is available to authorized users. Springer US 2017-08-04 2017 /pmc/articles/PMC5663794/ /pubmed/28779461 http://dx.doi.org/10.1007/s11060-017-2582-x Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Study
Wegenschimmel, Barbara
Leiss, Ulrike
Veigl, Michaela
Rosenmayr, Verena
Formann, Anton
Slavc, Irene
Pletschko, Thomas
Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study
title Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study
title_full Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study
title_fullStr Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study
title_full_unstemmed Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study
title_short Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study
title_sort do we still need iq-scores? misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663794/
https://www.ncbi.nlm.nih.gov/pubmed/28779461
http://dx.doi.org/10.1007/s11060-017-2582-x
work_keys_str_mv AT wegenschimmelbarbara dowestillneediqscoresmisleadinginterpretationsofneurocognitiveoutcomeinpediatricpatientswithmedulloblastomaaretrospectivestudy
AT leissulrike dowestillneediqscoresmisleadinginterpretationsofneurocognitiveoutcomeinpediatricpatientswithmedulloblastomaaretrospectivestudy
AT veiglmichaela dowestillneediqscoresmisleadinginterpretationsofneurocognitiveoutcomeinpediatricpatientswithmedulloblastomaaretrospectivestudy
AT rosenmayrverena dowestillneediqscoresmisleadinginterpretationsofneurocognitiveoutcomeinpediatricpatientswithmedulloblastomaaretrospectivestudy
AT formannanton dowestillneediqscoresmisleadinginterpretationsofneurocognitiveoutcomeinpediatricpatientswithmedulloblastomaaretrospectivestudy
AT slavcirene dowestillneediqscoresmisleadinginterpretationsofneurocognitiveoutcomeinpediatricpatientswithmedulloblastomaaretrospectivestudy
AT pletschkothomas dowestillneediqscoresmisleadinginterpretationsofneurocognitiveoutcomeinpediatricpatientswithmedulloblastomaaretrospectivestudy